RGH-1756

• Description :

  RGH-1756 is an atypical antipsychotic that has a strong and selective antagonist activity on human D3 and less pronounced activity on human D2L and 5HT1A receptors[1].

• UNSPSC :

  12352005

• Target :

  5-HT Receptor; Dopamine Receptor

• Type :

  Reference compound

• Related Pathways :

  GPCR/G Protein; Neuronal Signaling

• Applications :

  Neuroscience-Neuromodulation

• Field of Research :

  Neurological Disease

• Assay Protocol :

  https://www.medchemexpress.com/rgh-1756.html

• Smiles :

  COC1=CC=CC=C1N2CCN(CC2)CCCCOC3=CC=C(C=C3)C4=CN5C(SC=C5)=N4

• Molecular Formula :

  C26H30N4O2S

• Molecular Weight :

  462.61

• References & Citations :

  [1]Terjéki E, Kapás M. An HPLC/UV method for the determination of RGH-1756 in dog and rat plasma. J Pharm Biomed Anal. 2001 Mar;24 (5-6) :913-20.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• Isoform :

  5-HT1 Receptor

• CAS Number :

  [207277-37-0]